-
Something wrong with this record ?
Use of non-thermal plasma pre-treatment to enhance antibiotic action against mature Pseudomonas aeruginosa biofilms
M. Paldrychová, E. Vaňková, P. Kašparová, E. Sembolová, O. Maťátková, J. Masák, V. Scholtz, J. Julák
Language English Country Germany
Document type Journal Article
Grant support
CZ.2.16/3.1.00/24503
Operational Programme Prague - Competitiveness (CZ.2.16/3.1.00/24503)
Q25
Charles University research program Progress Q25
NPU I LO1601
National Programme of Sustainability I - NPU I LO1601
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Atmospheric Pressure MeSH
- Biofilms drug effects MeSH
- Ceftazidime pharmacology MeSH
- Gentamicins pharmacology MeSH
- Microscopy, Electron, Scanning MeSH
- Plasma Gases MeSH
- Polymyxin B pharmacology MeSH
- Pseudomonas aeruginosa drug effects metabolism MeSH
- Titanium chemistry MeSH
- Publication type
- Journal Article MeSH
Non-thermal plasma (NTP), generated at atmospheric pressure by DC cometary discharge with a metallic grid, and antibiotics (gentamicin-GTM, ceftazidime-CFZ and polymyxin B-PMB), either alone or in combination, were used to eradicate the mature biofilm of Pseudomonas aeruginosa formed on Ti-6Al-4V alloy. Our aim was to find the conditions for NTP pre-treatment capable of enhancing the action of the antibiotics and thus reducing their effective concentrations. The NTP treatment increased the efficacy of relatively low concentrations of antibiotics. Generally, the highest effect was achieved with GTM, which was able to suppress the metabolic activity of pre-formed P. aeruginosa biofilms in the concentration range of 4-9 mg/L by up to 99%. In addition, an apparent decrease of biofilm-covered area was confirmed after combined NTP treatment and GTM action by SYTO®13 staining using fluorescence microscopy. Scanning electron microscopy confirmed a complete eradication of P. aeruginosa ATCC 15442 mature biofilm from Ti-6Al-4V alloy when using 0.25 h NTP treatment and subsequent treatment by 8.5 mg/L GTM. Therefore, NTP may be used as a suitable antibiofilm agent in combination with antibiotics for the treatment of biofilm-associated infections caused by this pathogen.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012365
- 003
- CZ-PrNML
- 005
- 20230601084954.0
- 007
- ta
- 008
- 210420s2020 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11274-020-02891-6 $2 doi
- 035 __
- $a (PubMed)32656596
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Paldrychová, Martina $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic ; Department of Physics and Measurements, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 245 10
- $a Use of non-thermal plasma pre-treatment to enhance antibiotic action against mature Pseudomonas aeruginosa biofilms / $c M. Paldrychová, E. Vaňková, P. Kašparová, E. Sembolová, O. Maťátková, J. Masák, V. Scholtz, J. Julák
- 520 9_
- $a Non-thermal plasma (NTP), generated at atmospheric pressure by DC cometary discharge with a metallic grid, and antibiotics (gentamicin-GTM, ceftazidime-CFZ and polymyxin B-PMB), either alone or in combination, were used to eradicate the mature biofilm of Pseudomonas aeruginosa formed on Ti-6Al-4V alloy. Our aim was to find the conditions for NTP pre-treatment capable of enhancing the action of the antibiotics and thus reducing their effective concentrations. The NTP treatment increased the efficacy of relatively low concentrations of antibiotics. Generally, the highest effect was achieved with GTM, which was able to suppress the metabolic activity of pre-formed P. aeruginosa biofilms in the concentration range of 4-9 mg/L by up to 99%. In addition, an apparent decrease of biofilm-covered area was confirmed after combined NTP treatment and GTM action by SYTO®13 staining using fluorescence microscopy. Scanning electron microscopy confirmed a complete eradication of P. aeruginosa ATCC 15442 mature biofilm from Ti-6Al-4V alloy when using 0.25 h NTP treatment and subsequent treatment by 8.5 mg/L GTM. Therefore, NTP may be used as a suitable antibiofilm agent in combination with antibiotics for the treatment of biofilm-associated infections caused by this pathogen.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a atmosférický tlak $7 D001274
- 650 _2
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a ceftazidim $x farmakologie $7 D002442
- 650 _2
- $a gentamiciny $x farmakologie $7 D005839
- 650 _2
- $a mikroskopie elektronová rastrovací $7 D008855
- 650 _2
- $a plazmové plyny $7 D058626
- 650 _2
- $a polymyxin B $x farmakologie $7 D011112
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $x metabolismus $7 D011550
- 650 _2
- $a titan $x chemie $7 D014025
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vaňková, Eva $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic. Eva.Vankova@vscht.cz ; Department of Physics and Measurements, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic. Eva.Vankova@vscht.cz
- 700 1_
- $a Kašparová, Petra $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Sembolová, Eliška $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Maťátková, Olga $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic $7 jo2017970315
- 700 1_
- $a Masák, Jan $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Scholtz, Vladimír $u Department of Physics and Measurements, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Julák, Jaroslav $u Department of Physics and Measurements, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic ; Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00006402 $t World journal of microbiology & biotechnology incorporating the MIRCEN Journal of applied microbiology and biotechnology $x 1573-0972 $g Roč. 36, č. 8 (2020), s. 108
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32656596 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20230601084947 $b ABA008
- 999 __
- $a ok $b bmc $g 1650687 $s 1132744
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 36 $c 8 $d 108 $e 20200713 $i 1573-0972 $m World journal of microbiology & biotechnology incorporating the MIRCEN Journal of applied microbiology and biotechnology $n World j. microbiol. biotechnol. $x MED00006402
- GRA __
- $a CZ.2.16/3.1.00/24503 $p Operational Programme Prague - Competitiveness (CZ.2.16/3.1.00/24503)
- GRA __
- $a Q25 $p Charles University research program Progress Q25
- GRA __
- $a NPU I LO1601 $p National Programme of Sustainability I - NPU I LO1601
- LZP __
- $a Pubmed-20210420